Bazedoxifene (Wyeth) |
| |
| Authors: | Gruber Christian Gruber Doris |
| |
| Affiliation: | Department of Gynecological Endocrinology and Reproductive Medicine, University of Vienna Medical School, A-1090 Vienna, Wahringer Gurtel 18-20, Austria. christian_gruber@chello.at |
| |
| Abstract: | Bazedoxifene is a tissue-specific selective estrogen receptor modulator being developed by Wyeth Pharmaceuticals (formerly Wyeth-Ayerst Laboratories) to be used alone for the prevention and treatment of osteoporosis in postmenopausal women and in combination with Premarin for menopausal symptoms. As of March and June 2004, worldwide phase III trials for bazedoxifene, and bazedoxifene in combination with Premarin, were ongoing. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
